2024 Germany Nucleic Acid Testing (NAT) Market Opportunities--Competitive Shares and Growth Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks

June 2024 | | ID: 22589E0AE3D5EN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.The report is available by section, and can be customized to specific information needs and budget. The report presents comprehensive analysis of the German molecular diagnostics market, including:Major issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.Five-year test volume and reagent sales forecasts for the following categories:%li%Infectious Diseases%li%Forensic Testing%li%Cancer%li%Paternity Testing/HLA Typing%li%Genetic Diseases%li%OthersReview of testing methodologies an instrumentation technologies.Feature comparison of automated and semiautomated analyzers.Sales and market shares of leading suppliers.Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Alternative market penetration strategies.Potential market entry barriers and risks.Business planning issues and concerns.

Contents

Table of Contents
I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Market and Technology Review
A. DNA Sequencing

1. INTRODUCTION


2. SEQUENCING METHODS


3. AUTORADIOGRAPHY


4. THE HUMAN GENOME PROJECT


5. SEQUENCING AUTOMATION


6. IMAGE SCANNERS


7. FLUORESCENT DETECTION


8. GENE PROFILING


9. GENE EXPRESSION


10. POLYMORPHISM SCREENING


11. PROTEIN INTERACTION NETWORKS

Table of Contents (continued)
B. DNA and RNA Probe Technologies

1. BASIC PRINCIPLES


2. PROBE PREPARATION


3. THE DNA PROBE TEST


4. TEST FORMATS


5. LABELING TECHNIQUES


6. AMPLIFICATION METHODS

C. Detection Technologies

1. RADIOACTIVE METHODS


2. NON-ISOTOPIC METHODS

D. Instrumentation
Review of latest analyzers from Abbott, Beckm an Coulter/Danaher, Becton Dickinson, bioMerieux,
Bio-Rad, Cepheid, Hologic, Qiagen, Roche, Siemens Healthineers, and others.
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
F. Pharmacogenomics
G. Major Applications

1. MICROBIOLOGY/INFECTIOUS

Diseases
a. Overview
b. Major Infectious
Diseases
- AIDS/HIV
- Adenovirus
- Aeromonads
- Anthrax/Bacillus Anthracis
- Arboviruses
- Babesiosis
- Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
- Blastocystis Hominis
- Brucella
- Campylobacter
- Candida
- Chagas Disease